Genetic Test and Early Stage Non-Small-Cell Lung Cancer
A Duke University study concludes that the lung metagene model can predict with good accuracy which early stage lung cancer patients are likely to experience recurrence and therefore would benefit from chemotherapy. Currently, patients diagnosed with early stage non-small-cell lung cancer undergo surgery followed by observation, without chemotherapy.
Citation: Potti, A. et. al. "A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer." New England Journal of Medicine 355(6): 570-580, August 10, 2006.
Citation: Potti, A. et. al. "A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer." New England Journal of Medicine 355(6): 570-580, August 10, 2006.
